Tag Archives: JPMorgan Chase & Co.

The Divisional Chief Executive Officer of JPMorgan Chase & Co. is Exercising Options

Yesterday it was reported that the Divisional Chief Executive Officer of JPMorgan Chase & Co. (JPM – Research Report), Daniel E Pinto, exercised options to sell 52,679 JPM shares for a total transaction value of $5.32M. Following Daniel E Pinto’s

JPMorgan Chase & Co. (JPM) Receives a Buy from RBC Capital

RBC Capital analyst Gerard Cassidy maintained a Buy rating on JPMorgan Chase & Co. (JPM – Research Report) yesterday and set a price target of $110.00. The company’s shares closed last Tuesday at $100.78. According to TipRanks.com, Cassidy is a

JPMorgan Chase & Co. (JPM) Gets a Hold Rating from Goldman Sachs

In a report released today, Richard Ramsden from Goldman Sachs maintained a Hold rating on JPMorgan Chase & Co. (JPM – Research Report), with a price target of $100.00. The company’s shares closed last Tuesday at $98.40. According to TipRanks.com,

Oppenheimer Keeps a Hold Rating on JPMorgan Chase & Co. (JPM)

In a report released today, Chris Kotowski from Oppenheimer maintained a Hold rating on JPMorgan Chase & Co. (JPM – Research Report). The company’s shares closed last Monday at $97.65. According to TipRanks.com, Kotowski is a 4-star analyst with an

Oppenheimer Reaffirms Their Hold Rating on JPMorgan Chase & Co. (JPM)

In a report issued on July 2, Chris Kotowski from Oppenheimer maintained a Hold rating on JPMorgan Chase & Co. (JPM – Research Report). The company’s shares closed last Thursday at $92.66. According to TipRanks.com, Kotowski is a 4-star analyst

Analysts Offer Insights on Financial Companies: JPMorgan Chase & Co. (NYSE: JPM) and Diversified Healthcare Trust (NASDAQ: DHC)

Analysts have been eager to weigh in on the Financial sector with new ratings on JPMorgan Chase & Co. (JPM – Research Report) and Diversified Healthcare Trust (DHC – Research Report). JPMorgan Chase & Co. (JPM) In a report released